Back

Prolyl hydroxylase inhibition to enhance SDF-1 and CXCR4 expression for increased CXCR4+ cell homing and myocardial repair

29 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - Cell and gene therapy Stem cells and cell therapy ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Santhosh Kumar Ghadge

Medical University of Vienna, Vienna (Austria)

15 More presentations in this session

Presentation thumbnail
Doctor Y. Liu (New Taipei, TW)
Abstract
Presentation thumbnail
Associate Professor J. Oh (Seoul, KR)
Abstract
Presentation thumbnail
Doctor H. Masumoto (Osaka, JP)
Abstract Slides
Presentation thumbnail
Doctor E. Gara (Budapest, HU)
Abstract
Presentation thumbnail
Doctor O. Inoue (Kanazawa, JP)
Abstract Slides

Access the full session

Session thumbnail
Poster session 4 - Cell and gene therapy

The Event

Event poster

ESC Congress 2016

29 August 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Conditional ablation of SDF-1/CXCL12 in smooth muscle cells leads to severe cardiac hypertrophy and aortic valve stenosis
3 September 2019
thumbnail
Congress Presentation
Normobaric hypoxia and exercise training effects on cardiac biomarkers, left ventricular function and aerobic performance in patients after myocardial infarction
27 August 2023
thumbnail
Congress Presentation
Deficiency of myeloid prolyl hydroxylase domain proteins aggravates atherogenesis via macrophage apoptosis and paracrine fibrotic signaling
29 August 2021
thumbnail
Congress Presentation
Inhibition of fractalkine signalling reduces intramyocardial haemorrhage and left ventricular thrombus in patients with acute myocardial infarction by modulating immunothrombosis (The FRACTAL trial)
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources